ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Nuclear Nonproliferation Policy
The mission of the Nuclear Nonproliferation Policy Division (NNPD) is to promote the peaceful use of nuclear technology while simultaneously preventing the diversion and misuse of nuclear material and technology through appropriate safeguards and security, and promotion of nuclear nonproliferation policies. To achieve this mission, the objectives of the NNPD are to: Promote policy that discourages the proliferation of nuclear technology and material to inappropriate entities. Provide information to ANS members, the technical community at large, opinion leaders, and decision makers to improve their understanding of nuclear nonproliferation issues. Become a recognized technical resource on nuclear nonproliferation, safeguards, and security issues. Serve as the integration and coordination body for nuclear nonproliferation activities for the ANS. Work cooperatively with other ANS divisions to achieve these objective nonproliferation policies.
Meeting Spotlight
Utility Working Conference and Vendor Technology Expo (UWC 2024)
August 4–7, 2024
Marco Island, FL|JW Marriott Marco Island
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Jun 2024
Jan 2024
Latest Journal Issues
Nuclear Science and Engineering
August 2024
Nuclear Technology
July 2024
Fusion Science and Technology
Latest News
NRC engineers share their expertise at the University of Puerto Rico
Robert Roche-Rivera and Marcos Rolón-Acevedo are licensed professional engineers who work at the U.S. Nuclear Regulatory Commission. They are also alumni of the University of Puerto Rico–Mayagüez (UPRM) and have been sharing their knowledge and experience with students at their alma mater since last year, serving as adjunct professors in the university’s Department of Mechanical Engineering. During the 2023–2024 school year, they each taught two courses: Fundamentals of Nuclear Science and Engineering, and Nuclear Power Plant Engineering.
Yasunori Nakai, Kazuyuki Noborio, Yuto Takeuchi, Ryuta Kasada, Yasushi Yamamoto, Satoshi Konishi
Fusion Science and Technology | Volume 64 | Number 2 | August 2013 | Pages 379-383
Alternate Concepts/Applications | Proceedings of the Twentieth Topical Meeting on the Technology of Fusion Energy (TOFE-2012) (Part 1), Nashville, Tennessee, August 27-31, 2012 | doi.org/10.13182/FST13-A18106
Articles are hosted by Taylor and Francis Online.
An application of a cylindrical discharge tube type fusion neutron beam source for medical purpose was investigated. Practicality and possibility of the medical irradiation plan were evaluated from the standpoint of engineering and medicine.Cancer treatment by BNCT (Boron Neutron Capture Therapy) was selected as an effective application to take advantage of this neutron source. Neutron transport in a phantom was calculated with the MCNP5 (Monte Carlo Neutron Particle calculation code version5), and the distribution of dose on the affected part medicated with a boron agent suggested satisfactory focusing.Since this neutron source is small size, it is designed to irradiate the affected part from many directions by crossfire irradiation. Flexibility of attitude and operation modes permits irradiation in a supine position from arbitrary directions. Because of low neutron flux, irradiation therapy is planned for multi-fractionation in a manner similar to CHART (Continuous Hyperfractionated Accelerated Radio Therapy). Crossfire irradiation and CHART will allow us to achieve new cancer therapy with a relatively lower dose rate than conventional BNCT. It causes apoptosis selectively to a cancer cell, reducing side effects and a patient's recuperation burden. This result suggests the possibility of advanced cancer treatment which improves QOL (Quality of Life) of the patients.